United States· US:0002-1220_28ed503a-b3ed-40a3-a6e8-acdf613fa748
TAUVID
A medicinal product containing flortaucipir f-18, registered in United States by Eli Lilly and Company.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLORTAUCIPIR F-18
- Manufacturer
- Eli Lilly and Company
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1100021220481 VIAL, MULTI-DOSE in 1 CAN (0002-1220-48) / 100 mL in 1 VIAL, MULTI-DOSE
- ndc1100021220501 VIAL, MULTI-DOSE in 1 CAN (0002-1220-50) / 50 mL in 1 VIAL, MULTI-DOSE
- ndc110002-1220-48
- ndc110002-1220-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flortaucipir f-18 in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenTauvid 1900 MBq/ml Injektionsvätska, lösningEli Lilly Nederland B.V.
- CzechiaTAUVIDEli Lilly Nederland B.V., Utrecht
- FinlandTauvidEli Lilly Nederland B.V
- BelgiumTauvid 1900 MBq/mlEli Lilly Nederland
- IcelandTauvidEli Lilly Nederland B.V.*
- NetherlandsTauvid 1.900 MBq/ml oplossing voor injectieEli Lilly Nederland B.V.
- IrelandTauvid 800 MBq/mL solution for injectionEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tauvid
- Liechtenstein · Tauvid
- Norway · Tauvid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7e82e0b7-15be-4781-ac8e-10e4a50dba56 GET /v1/drugs/7e82e0b7-15be-4781-ac8e-10e4a50dba56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "100",
"substance": "FLORTAUCIPIR F-18",
"productndc": "0002-1220",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mCi/mL",
"application_number": "NDA212123",
"marketing_category": "NDA"
}See everything about flortaucipir f-18.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.